This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
RenaissanceRe (RNR) Q4 Earnings Beat on Solid Investment Income
by Zacks Equity Research
RenaissanceRe's (RNR) fourth-quarter results reflect a solid underwriting performance and improved investment income. A rise in expenses partially offsets its quarterly results.
Synchrony (SYF) Expands CareCredit Network With PatientNow
by Zacks Equity Research
Synchrony (SYF) and PatientNow collaborate to offer CareCredit as a financing option at 4,800 aesthetic and cosmetic businesses in the country.
SYF vs. VIRT: Which Stock Is the Better Value Option?
by Zacks Equity Research
SYF vs. VIRT: Which Stock Is the Better Value Option?
Are Investors Undervaluing Synchrony Financial (SYF) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AmEx (AXP) Q4 Earnings Miss on High Client Engagement Costs
by Zacks Equity Research
American Express' (AXP) Q4 results reflect escalating expenses resulting from increased usage of travel-related benefits. Management expects EPS in the range of $12.65-$13.15 for 2024.
Synchrony (SYF) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Synchrony (SYF) Q4 Earnings Beat on Robust Receivables Growth
by Zacks Equity Research
Synchrony (SYF) expects net interest income in the range of $17.5-18.5 billion for 2024, higher than the previous year's figure of $17 billion.
Compared to Estimates, Synchrony (SYF) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Synchrony (SYF) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Synchrony (SYF) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Synchrony (SYF) delivered earnings and revenue surprises of 7.29% and 0.34%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Synchrony (SYF) to Buy Ally Financial's Point-of-Sale Business
by Zacks Equity Research
Synchrony's (SYF) pending acquisition of Ally's point-of-sale financing business is likely to help it expand in home improvement and healthcare financing.
Ally Financial (ALLY) to Sell POS Financing Business to Synchrony
by Zacks Equity Research
With an aim to focus on core business, Ally Financial (ALLY) announces a deal to divest, Ally Lending, its POS financing business to Synchrony (SYF).
Synchrony (SYF) Opts for Tech Investment to Ease Online Checkouts
by Zacks Equity Research
Synchrony (SYF) is testing the feasibility of a browser extension in a bid to make online checkouts safer and, subsequently, generate higher sales from its cardholders.
Can Higher Expenses Affect Synchrony's (SYF) Q4 Earnings?
by Zacks Equity Research
Synchrony's (SYF) fourth-quarter results are likely to reflect rising total purchase volumes and lower net interest margins.
Virtu Financial (VIRT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Virtu Financial (VIRT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Unveiling Synchrony (SYF) Q4 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Synchrony (SYF), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
Earnings Preview: Synchrony (SYF) Q4 Earnings Expected to Decline
by Zacks Equity Research
Synchrony (SYF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synchrony (SYF) Strengthens Ties to Offer Improved Health Care
by Zacks Equity Research
Synchrony (SYF) renews its deal with The Good Feet Store for providing flexible financing options, thereby encouraging customers to purchase more personalized arch supports from the latter.
Synchrony (SYF) Expands CareCredit Offering With Destination Pet
by Zacks Equity Research
Synchrony (SYF) partners with Destination Pet to offer financing solutions to pet owners through its CareCredit card.
Time to Buy OneMain Holdings (OMF) Stock for Higher Highs?
by Shaun Pruitt
OneMain Holdings' (OMF) valuation and lucrative dividend yield remain enticing to income investors with shares hovering near 52-week highs.
Time to Buy Ally or Synchrony Financial Stock for Higher Highs?
by Shaun Pruitt
Several consumer lending stocks have been bright spots in the financial sector with Ally Financial (ALLY) and Synchrony Financial (SYF) standing out in particular.
Why You Should Hold Synchrony (SYF) Stock in Your Portfolio
by Zacks Equity Research
Synchrony's (SYF) product innovations, partnerships and rising purchase volumes poise it well for growth.
Why Is PRA Group (PRAA) Up 21.6% Since Last Earnings Report?
by Zacks Equity Research
PRA Group (PRAA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Strength Seen in Primis Financial (FRST): Can Its 5.2% Jump Turn into More Strength?
by Zacks Equity Research
Primis Financial (FRST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Synchrony (SYF) & HABRI Join Forces to Boost Human-Animal Bond
by Zacks Equity Research
Synchrony (SYF) is expected to promote HABRI's science-based education within CareCredit's extensive veterinary network.
Synchrony (SYF) to Issue Co-Branded Card for J.Crew Clients
by Zacks Equity Research
Synchrony (SYF) ties up with J.Crew Group and Mastercard to introduce a consumer financing program and offer higher rewards for J.Crew customers.